nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPRE—mammary gland—lung cancer	0.032	0.128	CbGeAlD
Alendronate—PTPN4—bronchus—lung cancer	0.0167	0.067	CbGeAlD
Alendronate—ATP6V1A—mammary gland—lung cancer	0.0151	0.0604	CbGeAlD
Alendronate—PTPRE—cardiac atrium—lung cancer	0.0148	0.0594	CbGeAlD
Alendronate—PTPRE—bone marrow—lung cancer	0.0125	0.0502	CbGeAlD
Alendronate—PTPN4—bone marrow—lung cancer	0.0119	0.0477	CbGeAlD
Alendronate—PTPRE—lung—lung cancer	0.0113	0.0455	CbGeAlD
Alendronate—PTPN4—lung—lung cancer	0.0108	0.0432	CbGeAlD
Alendronate—PTPRS—bone marrow—lung cancer	0.0102	0.0409	CbGeAlD
Alendronate—ATP6V1A—respiratory system—lung cancer	0.01	0.0402	CbGeAlD
Alendronate—PTPRS—lung—lung cancer	0.00924	0.0371	CbGeAlD
Alendronate—ATP6V1A—bronchus—lung cancer	0.00826	0.0331	CbGeAlD
Alendronate—PTPRE—lymph node—lung cancer	0.00775	0.0311	CbGeAlD
Alendronate—FDPS—respiratory system—lung cancer	0.00756	0.0303	CbGeAlD
Alendronate—ATP6V1A—trachea—lung cancer	0.00742	0.0297	CbGeAlD
Alendronate—PTPN4—lymph node—lung cancer	0.00738	0.0296	CbGeAlD
Alendronate—ATP6V1A—cardiac atrium—lung cancer	0.00697	0.0279	CbGeAlD
Alendronate—PTPRS—lymph node—lung cancer	0.00632	0.0253	CbGeAlD
Alendronate—FDPS—bronchus—lung cancer	0.00622	0.0249	CbGeAlD
Alendronate—ATP6V1A—bone marrow—lung cancer	0.00588	0.0236	CbGeAlD
Alendronate—FDPS—trachea—lung cancer	0.00559	0.0224	CbGeAlD
Alendronate—ATP6V1A—lung—lung cancer	0.00533	0.0214	CbGeAlD
Alendronate—FDPS—cardiac atrium—lung cancer	0.00525	0.021	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—STAT3—lung cancer	0.00474	0.0194	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—COL4A2—lung cancer	0.00448	0.0183	CbGpPWpGaD
Alendronate—FDPS—bone marrow—lung cancer	0.00443	0.0178	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—MYC—lung cancer	0.00441	0.018	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—SDC4—lung cancer	0.00407	0.0166	CbGpPWpGaD
Alendronate—FDPS—lung—lung cancer	0.00401	0.0161	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—PIK3CA—lung cancer	0.00374	0.0153	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—RHEB—lung cancer	0.00369	0.0151	CbGpPWpGaD
Alendronate—ATP6V1A—lymph node—lung cancer	0.00365	0.0146	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—ADAMTS1—lung cancer	0.00349	0.0143	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—IL6—lung cancer	0.00331	0.0135	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—AKT1—lung cancer	0.00306	0.0125	CbGpPWpGaD
Alendronate—FDPS—lymph node—lung cancer	0.00275	0.011	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—NCAM1—lung cancer	0.00257	0.0105	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—FGF9—lung cancer	0.00199	0.00814	CbGpPWpGaD
Alendronate—FDPS—Activation of gene expression by SREBF (SREBP)—CREBBP—lung cancer	0.00189	0.00774	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00174	0.00713	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—STK11—lung cancer	0.00173	0.00706	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—ITGB1—lung cancer	0.0017	0.00696	CbGpPWpGaD
Alendronate—Risedronate—PTGS2—lung cancer	0.00166	0.529	CrCbGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.0016	0.00656	CbGpPWpGaD
Alendronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CREBBP—lung cancer	0.00151	0.00618	CbGpPWpGaD
Alendronate—Clodronate—PTGS2—lung cancer	0.00148	0.471	CrCbGaD
Alendronate—PTPRS—Extracellular matrix organization—MMP1—lung cancer	0.00132	0.00541	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00132	0.00541	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—FGFR1—lung cancer	0.00126	0.00514	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—KDR—lung cancer	0.00126	0.00513	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.00122	0.00497	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—CDH1—lung cancer	0.00106	0.00435	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—MMP2—lung cancer	0.00102	0.00419	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6R—lung cancer	0.00101	0.00414	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—MTOR—lung cancer	0.00101	0.00414	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—MAP2K1—lung cancer	0.000965	0.00395	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000945	0.00387	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—RAF1—lung cancer	0.000856	0.0035	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—MTOR—lung cancer	0.000835	0.00342	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—PIK3CB—lung cancer	0.000835	0.00342	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—CASP3—lung cancer	0.000815	0.00333	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000792	0.00324	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—MMP9—lung cancer	0.00077	0.00315	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—GNG11—lung cancer	0.000718	0.00294	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AZIN2—lung cancer	0.000714	0.00292	CbGpPWpGaD
Alendronate—FDPS—Metabolism—COL4A3BP—lung cancer	0.000714	0.00292	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000666	0.00272	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000646	0.00264	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000646	0.00264	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000645	0.00264	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—NRAS—lung cancer	0.000644	0.00263	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—PIK3CA—lung cancer	0.000617	0.00252	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—MAPK3—lung cancer	0.000617	0.00252	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PGAM1—lung cancer	0.000613	0.00251	CbGpPWpGaD
Alendronate—Feeling abnormal—Vinorelbine—lung cancer	0.000608	0.00121	CcSEcCtD
Alendronate—Diarrhoea—Vinblastine—lung cancer	0.000608	0.00121	CcSEcCtD
Alendronate—Dysgeusia—Etoposide—lung cancer	0.000607	0.00121	CcSEcCtD
Alendronate—FDPS—Metabolism—ATP5H—lung cancer	0.000607	0.00248	CbGpPWpGaD
Alendronate—Infection—Irinotecan—lung cancer	0.000605	0.0012	CcSEcCtD
Alendronate—Pruritus—Erlotinib—lung cancer	0.000604	0.0012	CcSEcCtD
Alendronate—Gastrointestinal pain—Vinorelbine—lung cancer	0.000603	0.0012	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—TF—lung cancer	0.0006	0.00245	CbGpPWpGaD
Alendronate—Flatulence—Paclitaxel—lung cancer	0.000599	0.00119	CcSEcCtD
Alendronate—Muscle spasms—Etoposide—lung cancer	0.000596	0.00119	CcSEcCtD
Alendronate—Dysgeusia—Paclitaxel—lung cancer	0.000596	0.00118	CcSEcCtD
Alendronate—Haemoglobin—Docetaxel—lung cancer	0.000595	0.00118	CcSEcCtD
Alendronate—Haemorrhage—Docetaxel—lung cancer	0.000592	0.00118	CcSEcCtD
Alendronate—Diarrhoea—Topotecan—lung cancer	0.00059	0.00117	CcSEcCtD
Alendronate—Infection—Gemcitabine—lung cancer	0.000589	0.00117	CcSEcCtD
Alendronate—Dizziness—Vinblastine—lung cancer	0.000587	0.00117	CcSEcCtD
Alendronate—Urticaria—Vinorelbine—lung cancer	0.000586	0.00117	CcSEcCtD
Alendronate—Muscle spasms—Paclitaxel—lung cancer	0.000585	0.00116	CcSEcCtD
Alendronate—Diarrhoea—Erlotinib—lung cancer	0.000584	0.00116	CcSEcCtD
Alendronate—Abdominal pain—Vinorelbine—lung cancer	0.000583	0.00116	CcSEcCtD
Alendronate—Body temperature increased—Vinorelbine—lung cancer	0.000583	0.00116	CcSEcCtD
Alendronate—Oedema peripheral—Docetaxel—lung cancer	0.000583	0.00116	CcSEcCtD
Alendronate—Myalgia—Cisplatin—lung cancer	0.000576	0.00115	CcSEcCtD
Alendronate—Ill-defined disorder—Etoposide—lung cancer	0.000576	0.00114	CcSEcCtD
Alendronate—Anaemia—Etoposide—lung cancer	0.000573	0.00114	CcSEcCtD
Alendronate—ATP6V1A—Disease—SDC4—lung cancer	0.000572	0.00234	CbGpPWpGaD
Alendronate—Dizziness—Topotecan—lung cancer	0.00057	0.00113	CcSEcCtD
Alendronate—Discomfort—Cisplatin—lung cancer	0.00057	0.00113	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—AXL—lung cancer	0.000566	0.00232	CbGpPWpGaD
Alendronate—Vomiting—Vinblastine—lung cancer	0.000565	0.00112	CcSEcCtD
Alendronate—Dizziness—Erlotinib—lung cancer	0.000564	0.00112	CcSEcCtD
Alendronate—Ill-defined disorder—Paclitaxel—lung cancer	0.000564	0.00112	CcSEcCtD
Alendronate—Anaemia—Paclitaxel—lung cancer	0.000562	0.00112	CcSEcCtD
Alendronate—Erythema multiforme—Docetaxel—lung cancer	0.00056	0.00111	CcSEcCtD
Alendronate—Malaise—Etoposide—lung cancer	0.000559	0.00111	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000558	0.00228	CbGpPWpGaD
Alendronate—Vertigo—Etoposide—lung cancer	0.000557	0.00111	CcSEcCtD
Alendronate—Headache—Vinblastine—lung cancer	0.000556	0.00111	CcSEcCtD
Alendronate—Angioedema—Paclitaxel—lung cancer	0.000556	0.00111	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000556	0.0011	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—KRAS—lung cancer	0.000554	0.00227	CbGpPWpGaD
Alendronate—Infection—Cisplatin—lung cancer	0.000549	0.00109	CcSEcCtD
Alendronate—Vomiting—Topotecan—lung cancer	0.000548	0.00109	CcSEcCtD
Alendronate—Malaise—Paclitaxel—lung cancer	0.000548	0.00109	CcSEcCtD
Alendronate—Vertigo—Paclitaxel—lung cancer	0.000546	0.00109	CcSEcCtD
Alendronate—Rash—Topotecan—lung cancer	0.000544	0.00108	CcSEcCtD
Alendronate—Hypersensitivity—Vinorelbine—lung cancer	0.000544	0.00108	CcSEcCtD
Alendronate—Dermatitis—Topotecan—lung cancer	0.000543	0.00108	CcSEcCtD
Alendronate—Vomiting—Erlotinib—lung cancer	0.000543	0.00108	CcSEcCtD
Alendronate—FDPS—Metabolism—PLBD1—lung cancer	0.000541	0.00221	CbGpPWpGaD
Alendronate—Headache—Topotecan—lung cancer	0.00054	0.00107	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.00054	0.00107	CcSEcCtD
Alendronate—Rash—Erlotinib—lung cancer	0.000538	0.00107	CcSEcCtD
Alendronate—Dermatitis—Erlotinib—lung cancer	0.000538	0.00107	CcSEcCtD
Alendronate—Dyspepsia—Irinotecan—lung cancer	0.000536	0.00107	CcSEcCtD
Alendronate—Headache—Erlotinib—lung cancer	0.000535	0.00106	CcSEcCtD
Alendronate—Asthma—Methotrexate—lung cancer	0.000533	0.00106	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000532	0.00218	CbGpPWpGaD
Alendronate—Asthenia—Vinorelbine—lung cancer	0.000529	0.00105	CcSEcCtD
Alendronate—Chest pain—Etoposide—lung cancer	0.000528	0.00105	CcSEcCtD
Alendronate—Nausea—Vinblastine—lung cancer	0.000527	0.00105	CcSEcCtD
Alendronate—Alopecia—Docetaxel—lung cancer	0.000523	0.00104	CcSEcCtD
Alendronate—Pruritus—Vinorelbine—lung cancer	0.000522	0.00104	CcSEcCtD
Alendronate—Discomfort—Etoposide—lung cancer	0.000522	0.00104	CcSEcCtD
Alendronate—Constipation—Irinotecan—lung cancer	0.00052	0.00103	CcSEcCtD
Alendronate—Pain—Irinotecan—lung cancer	0.00052	0.00103	CcSEcCtD
Alendronate—Chest pain—Paclitaxel—lung cancer	0.000518	0.00103	CcSEcCtD
Alendronate—Myalgia—Paclitaxel—lung cancer	0.000518	0.00103	CcSEcCtD
Alendronate—Erythema—Docetaxel—lung cancer	0.000515	0.00103	CcSEcCtD
Alendronate—Nausea—Topotecan—lung cancer	0.000512	0.00102	CcSEcCtD
Alendronate—Discomfort—Paclitaxel—lung cancer	0.000512	0.00102	CcSEcCtD
Alendronate—Abdominal discomfort—Methotrexate—lung cancer	0.000511	0.00102	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—PIK3CA—lung cancer	0.000509	0.00208	CbGpPWpGaD
Alendronate—Pain—Gemcitabine—lung cancer	0.000507	0.00101	CcSEcCtD
Alendronate—Constipation—Gemcitabine—lung cancer	0.000507	0.00101	CcSEcCtD
Alendronate—Nausea—Erlotinib—lung cancer	0.000507	0.00101	CcSEcCtD
Alendronate—Diarrhoea—Vinorelbine—lung cancer	0.000505	0.001	CcSEcCtD
Alendronate—Dysgeusia—Docetaxel—lung cancer	0.000505	0.001	CcSEcCtD
Alendronate—ATP6V1A—Disease—SKI—lung cancer	0.000505	0.00206	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—AKT1—lung cancer	0.000504	0.00206	CbGpPWpGaD
Alendronate—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000503	0.001	CcSEcCtD
Alendronate—Infection—Etoposide—lung cancer	0.000503	0.001	CcSEcCtD
Alendronate—Feeling abnormal—Irinotecan—lung cancer	0.000502	0.000997	CcSEcCtD
Alendronate—Gastrointestinal pain—Irinotecan—lung cancer	0.000498	0.00099	CcSEcCtD
Alendronate—Muscle spasms—Docetaxel—lung cancer	0.000496	0.000986	CcSEcCtD
Alendronate—FDPS—Metabolism—HSD17B10—lung cancer	0.000495	0.00202	CbGpPWpGaD
Alendronate—Infection—Paclitaxel—lung cancer	0.000493	0.000981	CcSEcCtD
Alendronate—ATP6V1A—Disease—B4GALT5—lung cancer	0.00049	0.002	CbGpPWpGaD
Alendronate—Dry skin—Doxorubicin—lung cancer	0.00049	0.000974	CcSEcCtD
Alendronate—Feeling abnormal—Gemcitabine—lung cancer	0.000489	0.000972	CcSEcCtD
Alendronate—Dizziness—Vinorelbine—lung cancer	0.000488	0.00097	CcSEcCtD
Alendronate—Photosensitivity reaction—Methotrexate—lung cancer	0.000487	0.000968	CcSEcCtD
Alendronate—Abdominal pain—Irinotecan—lung cancer	0.000481	0.000957	CcSEcCtD
Alendronate—Body temperature increased—Irinotecan—lung cancer	0.000481	0.000957	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000481	0.000957	CcSEcCtD
Alendronate—Anaemia—Docetaxel—lung cancer	0.000476	0.000947	CcSEcCtD
Alendronate—Gastritis—Doxorubicin—lung cancer	0.000473	0.00094	CcSEcCtD
Alendronate—Pain—Cisplatin—lung cancer	0.000473	0.00094	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000471	0.000937	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—HRAS—lung cancer	0.000471	0.00193	CbGpPWpGaD
Alendronate—Vomiting—Vinorelbine—lung cancer	0.000469	0.000933	CcSEcCtD
Alendronate—Body temperature increased—Gemcitabine—lung cancer	0.000469	0.000932	CcSEcCtD
Alendronate—Rash—Vinorelbine—lung cancer	0.000465	0.000925	CcSEcCtD
Alendronate—Dermatitis—Vinorelbine—lung cancer	0.000465	0.000924	CcSEcCtD
Alendronate—Abdominal distension—Doxorubicin—lung cancer	0.000465	0.000924	CcSEcCtD
Alendronate—Stomatitis—Methotrexate—lung cancer	0.000463	0.000922	CcSEcCtD
Alendronate—Headache—Vinorelbine—lung cancer	0.000462	0.000919	CcSEcCtD
Alendronate—Asthma—Doxorubicin—lung cancer	0.000462	0.000918	CcSEcCtD
Alendronate—Dysphagia—Doxorubicin—lung cancer	0.000462	0.000918	CcSEcCtD
Alendronate—FDPS—Metabolism—CKB—lung cancer	0.00046	0.00188	CbGpPWpGaD
Alendronate—Feeling abnormal—Cisplatin—lung cancer	0.000455	0.000906	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000452	0.000899	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6—lung cancer	0.000451	0.00184	CbGpPWpGaD
Alendronate—Hypersensitivity—Irinotecan—lung cancer	0.000448	0.000892	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—COL4A2—lung cancer	0.00044	0.0018	CbGpPWpGaD
Alendronate—Myalgia—Docetaxel—lung cancer	0.000439	0.000873	CcSEcCtD
Alendronate—Chest pain—Docetaxel—lung cancer	0.000439	0.000873	CcSEcCtD
Alendronate—Nausea—Vinorelbine—lung cancer	0.000438	0.000872	CcSEcCtD
Alendronate—ATP6V1A—Disease—PXN—lung cancer	0.000438	0.00179	CbGpPWpGaD
Alendronate—Dyspepsia—Paclitaxel—lung cancer	0.000437	0.000869	CcSEcCtD
Alendronate—Body temperature increased—Cisplatin—lung cancer	0.000437	0.000869	CcSEcCtD
Alendronate—Asthenia—Irinotecan—lung cancer	0.000437	0.000868	CcSEcCtD
Alendronate—Pain—Etoposide—lung cancer	0.000433	0.000861	CcSEcCtD
Alendronate—Constipation—Etoposide—lung cancer	0.000433	0.000861	CcSEcCtD
Alendronate—FDPS—Metabolism—GSTM2—lung cancer	0.000433	0.00177	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CNDP2—lung cancer	0.000433	0.00177	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GIPR—lung cancer	0.000429	0.00175	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKR1C1—lung cancer	0.000429	0.00175	CbGpPWpGaD
Alendronate—Haemoglobin—Methotrexate—lung cancer	0.000429	0.000853	CcSEcCtD
Alendronate—Haemorrhage—Methotrexate—lung cancer	0.000427	0.000849	CcSEcCtD
Alendronate—Asthenia—Gemcitabine—lung cancer	0.000425	0.000846	CcSEcCtD
Alendronate—Pain—Paclitaxel—lung cancer	0.000424	0.000844	CcSEcCtD
Alendronate—Constipation—Paclitaxel—lung cancer	0.000424	0.000844	CcSEcCtD
Alendronate—Photosensitivity reaction—Doxorubicin—lung cancer	0.000421	0.000838	CcSEcCtD
Alendronate—FDPS—Metabolism—MTMR3—lung cancer	0.000421	0.00172	CbGpPWpGaD
Alendronate—Pruritus—Gemcitabine—lung cancer	0.000419	0.000834	CcSEcCtD
Alendronate—Infection—Docetaxel—lung cancer	0.000418	0.000831	CcSEcCtD
Alendronate—Feeling abnormal—Etoposide—lung cancer	0.000417	0.00083	CcSEcCtD
Alendronate—Diarrhoea—Irinotecan—lung cancer	0.000416	0.000828	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—AVP—lung cancer	0.000416	0.0017	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Etoposide—lung cancer	0.000414	0.000823	CcSEcCtD
Alendronate—FDPS—Metabolism—PGAM1—lung cancer	0.00041	0.00168	CbGpPWpGaD
Alendronate—Feeling abnormal—Paclitaxel—lung cancer	0.000409	0.000813	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000408	0.000812	CcSEcCtD
Alendronate—Hypersensitivity—Cisplatin—lung cancer	0.000407	0.00081	CcSEcCtD
Alendronate—Gastrointestinal pain—Paclitaxel—lung cancer	0.000406	0.000807	CcSEcCtD
Alendronate—Diarrhoea—Gemcitabine—lung cancer	0.000406	0.000807	CcSEcCtD
Alendronate—Erythema multiforme—Methotrexate—lung cancer	0.000404	0.000802	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000403	0.00165	CbGpPWpGaD
Alendronate—Dizziness—Irinotecan—lung cancer	0.000402	0.0008	CcSEcCtD
Alendronate—Urticaria—Etoposide—lung cancer	0.000402	0.0008	CcSEcCtD
Alendronate—Stomatitis—Doxorubicin—lung cancer	0.000401	0.000798	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—SDC4—lung cancer	0.000401	0.00164	CbGpPWpGaD
Alendronate—Body temperature increased—Etoposide—lung cancer	0.0004	0.000796	CcSEcCtD
Alendronate—Abdominal pain—Etoposide—lung cancer	0.0004	0.000796	CcSEcCtD
Alendronate—Asthenia—Cisplatin—lung cancer	0.000396	0.000788	CcSEcCtD
Alendronate—ATP6V1A—Disease—NPPA—lung cancer	0.000395	0.00161	CbGpPWpGaD
Alendronate—Urticaria—Paclitaxel—lung cancer	0.000394	0.000784	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—DUSP3—lung cancer	0.000392	0.0016	CbGpPWpGaD
Alendronate—Body temperature increased—Paclitaxel—lung cancer	0.000392	0.00078	CcSEcCtD
Alendronate—Abdominal pain—Paclitaxel—lung cancer	0.000392	0.00078	CcSEcCtD
Alendronate—FDPS—Metabolism—CYP2A7—lung cancer	0.000391	0.0016	CbGpPWpGaD
Alendronate—Vomiting—Irinotecan—lung cancer	0.000387	0.00077	CcSEcCtD
Alendronate—ATP6V1A—Disease—PPIA—lung cancer	0.000385	0.00158	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RHEB—lung cancer	0.000385	0.00157	CbGpPWpGaD
Alendronate—Rash—Irinotecan—lung cancer	0.000384	0.000763	CcSEcCtD
Alendronate—Dermatitis—Irinotecan—lung cancer	0.000383	0.000762	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000383	0.000762	CcSEcCtD
Alendronate—FDPS—Metabolism—SDC4—lung cancer	0.000383	0.00157	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ALDOA—lung cancer	0.000382	0.00156	CbGpPWpGaD
Alendronate—Headache—Irinotecan—lung cancer	0.000381	0.000758	CcSEcCtD
Alendronate—Diarrhoea—Cisplatin—lung cancer	0.000378	0.000752	CcSEcCtD
Alendronate—Alopecia—Methotrexate—lung cancer	0.000377	0.00075	CcSEcCtD
Alendronate—Vomiting—Gemcitabine—lung cancer	0.000377	0.00075	CcSEcCtD
Alendronate—Rash—Gemcitabine—lung cancer	0.000374	0.000743	CcSEcCtD
Alendronate—Dermatitis—Gemcitabine—lung cancer	0.000373	0.000743	CcSEcCtD
Alendronate—Hypersensitivity—Etoposide—lung cancer	0.000373	0.000742	CcSEcCtD
Alendronate—Erythema—Methotrexate—lung cancer	0.000372	0.000739	CcSEcCtD
Alendronate—Haemoglobin—Doxorubicin—lung cancer	0.000371	0.000739	CcSEcCtD
Alendronate—Headache—Gemcitabine—lung cancer	0.000371	0.000739	CcSEcCtD
Alendronate—Dyspepsia—Docetaxel—lung cancer	0.00037	0.000736	CcSEcCtD
Alendronate—Haemorrhage—Doxorubicin—lung cancer	0.00037	0.000735	CcSEcCtD
Alendronate—Hypersensitivity—Paclitaxel—lung cancer	0.000366	0.000727	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—GRM8—lung cancer	0.000365	0.00149	CbGpPWpGaD
Alendronate—Oedema peripheral—Doxorubicin—lung cancer	0.000364	0.000724	CcSEcCtD
Alendronate—Dysgeusia—Methotrexate—lung cancer	0.000364	0.000724	CcSEcCtD
Alendronate—Asthenia—Etoposide—lung cancer	0.000363	0.000722	CcSEcCtD
Alendronate—Nausea—Irinotecan—lung cancer	0.000362	0.000719	CcSEcCtD
Alendronate—ATP6V1A—Disease—ADCY1—lung cancer	0.000361	0.00148	CbGpPWpGaD
Alendronate—Pain—Docetaxel—lung cancer	0.00036	0.000715	CcSEcCtD
Alendronate—Constipation—Docetaxel—lung cancer	0.00036	0.000715	CcSEcCtD
Alendronate—Pruritus—Etoposide—lung cancer	0.000358	0.000712	CcSEcCtD
Alendronate—Asthenia—Paclitaxel—lung cancer	0.000356	0.000708	CcSEcCtD
Alendronate—ATP6V1A—Disease—ENO2—lung cancer	0.000354	0.00145	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SKI—lung cancer	0.000353	0.00144	CbGpPWpGaD
Alendronate—Nausea—Gemcitabine—lung cancer	0.000352	0.0007	CcSEcCtD
Alendronate—ATP6V1A—Disease—PPP2R1B—lung cancer	0.000352	0.00144	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SMARCA4—lung cancer	0.000352	0.00144	CbGpPWpGaD
Alendronate—Vomiting—Cisplatin—lung cancer	0.000351	0.000699	CcSEcCtD
Alendronate—Pruritus—Paclitaxel—lung cancer	0.000351	0.000698	CcSEcCtD
Alendronate—Erythema multiforme—Doxorubicin—lung cancer	0.000349	0.000695	CcSEcCtD
Alendronate—FDPS—Metabolism—RRM1—lung cancer	0.000349	0.00143	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTA3—lung cancer	0.000349	0.00143	CbGpPWpGaD
Alendronate—Rash—Cisplatin—lung cancer	0.000348	0.000693	CcSEcCtD
Alendronate—Dermatitis—Cisplatin—lung cancer	0.000348	0.000692	CcSEcCtD
Alendronate—Feeling abnormal—Docetaxel—lung cancer	0.000347	0.000689	CcSEcCtD
Alendronate—Diarrhoea—Etoposide—lung cancer	0.000346	0.000689	CcSEcCtD
Alendronate—Ill-defined disorder—Methotrexate—lung cancer	0.000345	0.000686	CcSEcCtD
Alendronate—Gastrointestinal pain—Docetaxel—lung cancer	0.000344	0.000684	CcSEcCtD
Alendronate—Anaemia—Methotrexate—lung cancer	0.000343	0.000683	CcSEcCtD
Alendronate—Diarrhoea—Paclitaxel—lung cancer	0.00034	0.000675	CcSEcCtD
Alendronate—Malaise—Methotrexate—lung cancer	0.000335	0.000666	CcSEcCtD
Alendronate—Dizziness—Etoposide—lung cancer	0.000335	0.000666	CcSEcCtD
Alendronate—Vertigo—Methotrexate—lung cancer	0.000334	0.000664	CcSEcCtD
Alendronate—Body temperature increased—Docetaxel—lung cancer	0.000333	0.000661	CcSEcCtD
Alendronate—Abdominal pain—Docetaxel—lung cancer	0.000333	0.000661	CcSEcCtD
Alendronate—Dizziness—Paclitaxel—lung cancer	0.000328	0.000653	CcSEcCtD
Alendronate—Nausea—Cisplatin—lung cancer	0.000328	0.000653	CcSEcCtD
Alendronate—FDPS—Metabolism—B4GALT5—lung cancer	0.000328	0.00134	CbGpPWpGaD
Alendronate—Alopecia—Doxorubicin—lung cancer	0.000327	0.000649	CcSEcCtD
Alendronate—ATP6V1A—Disease—ENO1—lung cancer	0.000322	0.00132	CbGpPWpGaD
Alendronate—Vomiting—Etoposide—lung cancer	0.000322	0.00064	CcSEcCtD
Alendronate—Erythema—Doxorubicin—lung cancer	0.000322	0.00064	CcSEcCtD
Alendronate—Rash—Etoposide—lung cancer	0.000319	0.000635	CcSEcCtD
Alendronate—FDPS—Metabolism—GSTA4—lung cancer	0.000319	0.0013	CbGpPWpGaD
Alendronate—Dermatitis—Etoposide—lung cancer	0.000319	0.000634	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—APOA1—lung cancer	0.000318	0.0013	CbGpPWpGaD
Alendronate—Headache—Etoposide—lung cancer	0.000317	0.000631	CcSEcCtD
Alendronate—Flatulence—Doxorubicin—lung cancer	0.000317	0.00063	CcSEcCtD
Alendronate—Myalgia—Methotrexate—lung cancer	0.000316	0.000629	CcSEcCtD
Alendronate—Chest pain—Methotrexate—lung cancer	0.000316	0.000629	CcSEcCtD
Alendronate—Vomiting—Paclitaxel—lung cancer	0.000316	0.000628	CcSEcCtD
Alendronate—Dysgeusia—Doxorubicin—lung cancer	0.000315	0.000627	CcSEcCtD
Alendronate—Rash—Paclitaxel—lung cancer	0.000313	0.000622	CcSEcCtD
Alendronate—Dermatitis—Paclitaxel—lung cancer	0.000313	0.000622	CcSEcCtD
Alendronate—Discomfort—Methotrexate—lung cancer	0.000313	0.000621	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000312	0.00128	CbGpPWpGaD
Alendronate—Headache—Paclitaxel—lung cancer	0.000311	0.000618	CcSEcCtD
Alendronate—FDPS—Metabolism—GSTA2—lung cancer	0.000311	0.00127	CbGpPWpGaD
Alendronate—Hypersensitivity—Docetaxel—lung cancer	0.00031	0.000616	CcSEcCtD
Alendronate—Muscle spasms—Doxorubicin—lung cancer	0.000309	0.000615	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PXN—lung cancer	0.000307	0.00125	CbGpPWpGaD
Alendronate—Asthenia—Docetaxel—lung cancer	0.000302	0.0006	CcSEcCtD
Alendronate—Infection—Methotrexate—lung cancer	0.000301	0.000599	CcSEcCtD
Alendronate—Nausea—Etoposide—lung cancer	0.000301	0.000598	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—OXTR—lung cancer	0.0003	0.00123	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRP—lung cancer	0.0003	0.00123	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKR1C1—lung cancer	0.0003	0.00123	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTA1—lung cancer	0.0003	0.00123	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APP—lung cancer	0.000299	0.00122	CbGpPWpGaD
Alendronate—Ill-defined disorder—Doxorubicin—lung cancer	0.000298	0.000594	CcSEcCtD
Alendronate—Pruritus—Docetaxel—lung cancer	0.000298	0.000592	CcSEcCtD
Alendronate—Anaemia—Doxorubicin—lung cancer	0.000297	0.000591	CcSEcCtD
Alendronate—ATP6V1A—Disease—FGF9—lung cancer	0.000297	0.00121	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCC3—lung cancer	0.000297	0.00121	CbGpPWpGaD
Alendronate—Nausea—Paclitaxel—lung cancer	0.000295	0.000586	CcSEcCtD
Alendronate—Malaise—Doxorubicin—lung cancer	0.00029	0.000577	CcSEcCtD
Alendronate—Vertigo—Doxorubicin—lung cancer	0.000289	0.000575	CcSEcCtD
Alendronate—Diarrhoea—Docetaxel—lung cancer	0.000288	0.000572	CcSEcCtD
Alendronate—FDPS—Metabolism—AKR1C1—lung cancer	0.000287	0.00117	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—JUNB—lung cancer	0.000283	0.00116	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GNG11—lung cancer	0.000281	0.00115	CbGpPWpGaD
Alendronate—FDPS—Metabolism—UGT1A1—lung cancer	0.000279	0.00114	CbGpPWpGaD
Alendronate—Dizziness—Docetaxel—lung cancer	0.000278	0.000553	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000276	0.000549	CcSEcCtD
Alendronate—Myalgia—Doxorubicin—lung cancer	0.000274	0.000545	CcSEcCtD
Alendronate—Chest pain—Doxorubicin—lung cancer	0.000274	0.000545	CcSEcCtD
Alendronate—Discomfort—Doxorubicin—lung cancer	0.000271	0.000538	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000269	0.0011	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GNG11—lung cancer	0.000269	0.0011	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFC—lung cancer	0.000268	0.00109	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.000268	0.00109	CbGpPWpGaD
Alendronate—Vomiting—Docetaxel—lung cancer	0.000267	0.000532	CcSEcCtD
Alendronate—Dyspepsia—Methotrexate—lung cancer	0.000267	0.000531	CcSEcCtD
Alendronate—Rash—Docetaxel—lung cancer	0.000265	0.000528	CcSEcCtD
Alendronate—Dermatitis—Docetaxel—lung cancer	0.000265	0.000527	CcSEcCtD
Alendronate—Headache—Docetaxel—lung cancer	0.000264	0.000524	CcSEcCtD
Alendronate—Infection—Doxorubicin—lung cancer	0.000261	0.000519	CcSEcCtD
Alendronate—Pain—Methotrexate—lung cancer	0.000259	0.000516	CcSEcCtD
Alendronate—FDPS—Metabolism—ALDOA—lung cancer	0.000256	0.00105	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADCY1—lung cancer	0.000253	0.00103	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ALB—lung cancer	0.000252	0.00103	CbGpPWpGaD
Alendronate—Nausea—Docetaxel—lung cancer	0.00025	0.000497	CcSEcCtD
Alendronate—Feeling abnormal—Methotrexate—lung cancer	0.00025	0.000497	CcSEcCtD
Alendronate—FDPS—Metabolism—NCOA3—lung cancer	0.000249	0.00102	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FOXO3—lung cancer	0.000248	0.00102	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Methotrexate—lung cancer	0.000248	0.000493	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—SMARCA4—lung cancer	0.000246	0.00101	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PPP2R1B—lung cancer	0.000246	0.00101	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.000244	0.000999	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ADCY1—lung cancer	0.000242	0.000989	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCG2—lung cancer	0.000242	0.000989	CbGpPWpGaD
Alendronate—Urticaria—Methotrexate—lung cancer	0.000241	0.000479	CcSEcCtD
Alendronate—Body temperature increased—Methotrexate—lung cancer	0.00024	0.000477	CcSEcCtD
Alendronate—Abdominal pain—Methotrexate—lung cancer	0.00024	0.000477	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000239	0.000476	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—HSPB1—lung cancer	0.000238	0.000972	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HPGDS—lung cancer	0.000237	0.00097	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ENO2—lung cancer	0.000237	0.00097	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPP2R1B—lung cancer	0.000236	0.000963	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTHLH—lung cancer	0.000235	0.000961	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.000232	0.000951	CbGpPWpGaD
Alendronate—Dyspepsia—Doxorubicin—lung cancer	0.000231	0.00046	CcSEcCtD
Alendronate—FDPS—Metabolism—GSTT1—lung cancer	0.00023	0.00094	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—RAF1—lung cancer	0.000228	0.000932	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GCLC—lung cancer	0.000227	0.00093	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2A6—lung cancer	0.000227	0.00093	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.000226	0.000926	CbGpPWpGaD
Alendronate—Constipation—Doxorubicin—lung cancer	0.000225	0.000447	CcSEcCtD
Alendronate—Pain—Doxorubicin—lung cancer	0.000225	0.000447	CcSEcCtD
Alendronate—Hypersensitivity—Methotrexate—lung cancer	0.000223	0.000444	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—ANXA1—lung cancer	0.000221	0.000904	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HES1—lung cancer	0.00022	0.0009	CbGpPWpGaD
Alendronate—Asthenia—Methotrexate—lung cancer	0.000218	0.000433	CcSEcCtD
Alendronate—Feeling abnormal—Doxorubicin—lung cancer	0.000216	0.00043	CcSEcCtD
Alendronate—FDPS—Metabolism—ENO1—lung cancer	0.000216	0.000881	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.000215	0.000878	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Doxorubicin—lung cancer	0.000215	0.000427	CcSEcCtD
Alendronate—Pruritus—Methotrexate—lung cancer	0.000215	0.000427	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FLT1—lung cancer	0.000214	0.000875	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.000212	0.000867	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APP—lung cancer	0.00021	0.000857	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOTCH3—lung cancer	0.00021	0.000857	CbGpPWpGaD
Alendronate—Urticaria—Doxorubicin—lung cancer	0.000209	0.000415	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FGF9—lung cancer	0.000208	0.00085	CbGpPWpGaD
Alendronate—Abdominal pain—Doxorubicin—lung cancer	0.000208	0.000413	CcSEcCtD
Alendronate—Body temperature increased—Doxorubicin—lung cancer	0.000208	0.000413	CcSEcCtD
Alendronate—Diarrhoea—Methotrexate—lung cancer	0.000207	0.000413	CcSEcCtD
Alendronate—ATP6V1A—Disease—ERCC2—lung cancer	0.000206	0.000841	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ERBB3—lung cancer	0.000201	0.000823	CbGpPWpGaD
Alendronate—Dizziness—Methotrexate—lung cancer	0.000201	0.000399	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—JUNB—lung cancer	0.000198	0.000811	CbGpPWpGaD
Alendronate—Hypersensitivity—Doxorubicin—lung cancer	0.000193	0.000385	CcSEcCtD
Alendronate—FDPS—Metabolism—CYP2E1—lung cancer	0.000193	0.00079	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TERT—lung cancer	0.000193	0.000788	CbGpPWpGaD
Alendronate—Vomiting—Methotrexate—lung cancer	0.000193	0.000383	CcSEcCtD
Alendronate—Rash—Methotrexate—lung cancer	0.000191	0.00038	CcSEcCtD
Alendronate—FDPS—Metabolism—NQO1—lung cancer	0.000191	0.000781	CbGpPWpGaD
Alendronate—Dermatitis—Methotrexate—lung cancer	0.000191	0.00038	CcSEcCtD
Alendronate—Headache—Methotrexate—lung cancer	0.00019	0.000378	CcSEcCtD
Alendronate—Asthenia—Doxorubicin—lung cancer	0.000188	0.000375	CcSEcCtD
Alendronate—ATP6V1A—Disease—FGFR1—lung cancer	0.000187	0.000766	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	0.000187	0.000765	CbGpPWpGaD
Alendronate—Pruritus—Doxorubicin—lung cancer	0.000186	0.000369	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	0.000185	0.000758	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HIF1A—lung cancer	0.000184	0.000754	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STK11—lung cancer	0.00018	0.000737	CbGpPWpGaD
Alendronate—Nausea—Methotrexate—lung cancer	0.00018	0.000358	CcSEcCtD
Alendronate—Diarrhoea—Doxorubicin—lung cancer	0.00018	0.000357	CcSEcCtD
Alendronate—ATP6V1A—Disease—APOA1—lung cancer	0.000178	0.000728	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FOXO3—lung cancer	0.000174	0.000711	CbGpPWpGaD
Alendronate—Dizziness—Doxorubicin—lung cancer	0.000174	0.000345	CcSEcCtD
Alendronate—FDPS—Metabolism—STK11—lung cancer	0.000172	0.000704	CbGpPWpGaD
Alendronate—Vomiting—Doxorubicin—lung cancer	0.000167	0.000332	CcSEcCtD
Alendronate—Rash—Doxorubicin—lung cancer	0.000166	0.000329	CcSEcCtD
Alendronate—Dermatitis—Doxorubicin—lung cancer	0.000165	0.000329	CcSEcCtD
Alendronate—Headache—Doxorubicin—lung cancer	0.000164	0.000327	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—AVP—lung cancer	0.000163	0.000666	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—KIT—lung cancer	0.000162	0.000664	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APC—lung cancer	0.000162	0.000664	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—lung cancer	0.000162	0.000661	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGF—lung cancer	0.000161	0.000657	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTP1—lung cancer	0.000159	0.000652	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1R—lung cancer	0.000157	0.000641	CbGpPWpGaD
Alendronate—Nausea—Doxorubicin—lung cancer	0.000156	0.00031	CcSEcCtD
Alendronate—FDPS—Metabolism—CAT—lung cancer	0.000155	0.000634	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—EP300—lung cancer	0.000154	0.000631	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HES1—lung cancer	0.000154	0.00063	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—BRAF—lung cancer	0.000153	0.000624	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCB1—lung cancer	0.000151	0.000617	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6R—lung cancer	0.000151	0.000617	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CREBBP—lung cancer	0.000151	0.000616	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TYMS—lung cancer	0.000148	0.000606	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTM1—lung cancer	0.000146	0.000599	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MAP2K1—lung cancer	0.000144	0.000588	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CD—lung cancer	0.000143	0.000584	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ERBB3—lung cancer	0.000141	0.000576	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP1A1—lung cancer	0.000139	0.000568	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ERCC2—lung cancer	0.000138	0.000563	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TERT—lung cancer	0.000135	0.000552	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGFR1—lung cancer	0.000131	0.000536	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HIF1A—lung cancer	0.000129	0.000528	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MDM2—lung cancer	0.000128	0.000523	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RAF1—lung cancer	0.000128	0.000521	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ERBB2—lung cancer	0.000126	0.000516	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOA1—lung cancer	0.000125	0.00051	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTOR—lung cancer	0.000124	0.000509	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CB—lung cancer	0.000124	0.000509	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CD4—lung cancer	0.000124	0.000508	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KDR—lung cancer	0.000124	0.000505	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTGS2—lung cancer	0.000123	0.000504	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOA1—lung cancer	0.000119	0.000487	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	0.000114	0.000466	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KIT—lung cancer	0.000114	0.000465	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CG—lung cancer	0.000114	0.000465	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APC—lung cancer	0.000114	0.000465	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGF—lung cancer	0.000112	0.00046	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CG—lung cancer	0.000109	0.000445	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—POMC—lung cancer	0.000108	0.000443	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CDKN1A—lung cancer	0.000108	0.000441	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTEN—lung cancer	0.000108	0.00044	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—BRAF—lung cancer	0.000107	0.000437	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6R—lung cancer	0.000106	0.000432	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CREBBP—lung cancer	0.000105	0.000431	CbGpPWpGaD
Alendronate—FDPS—Metabolism—POMC—lung cancer	0.000104	0.000423	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EP300—lung cancer	0.000103	0.000419	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CREBBP—lung cancer	0.000101	0.000412	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAP2K1—lung cancer	0.000101	0.000412	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CD—lung cancer	0.0001	0.000409	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SRC—lung cancer	9.98e-05	0.000408	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STAT3—lung cancer	9.62e-05	0.000393	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NRAS—lung cancer	9.6e-05	0.000392	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CD—lung cancer	9.56e-05	0.000391	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALB—lung cancer	9.44e-05	0.000386	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MAPK3—lung cancer	9.19e-05	0.000376	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MDM2—lung cancer	8.96e-05	0.000366	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MYC—lung cancer	8.94e-05	0.000366	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RAF1—lung cancer	8.93e-05	0.000365	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ERBB2—lung cancer	8.83e-05	0.000361	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGFR—lung cancer	8.74e-05	0.000358	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CB—lung cancer	8.72e-05	0.000356	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MTOR—lung cancer	8.72e-05	0.000356	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL8—lung cancer	8.38e-05	0.000343	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CB—lung cancer	8.33e-05	0.000341	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—KRAS—lung cancer	8.26e-05	0.000338	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS2—lung cancer	8.26e-05	0.000338	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CASP3—lung cancer	8.02e-05	0.000328	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL2—lung cancer	8.01e-05	0.000327	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCND1—lung cancer	7.8e-05	0.000319	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JUN—lung cancer	7.79e-05	0.000318	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CA—lung cancer	7.59e-05	0.00031	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP9—lung cancer	7.58e-05	0.00031	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDKN1A—lung cancer	7.55e-05	0.000309	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTEN—lung cancer	7.53e-05	0.000308	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTEN—lung cancer	7.2e-05	0.000294	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EP300—lung cancer	7.18e-05	0.000294	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HRAS—lung cancer	7.02e-05	0.000287	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SRC—lung cancer	6.99e-05	0.000286	CbGpPWpGaD
Alendronate—FDPS—Metabolism—EP300—lung cancer	6.87e-05	0.000281	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—lung cancer	6.8e-05	0.000278	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STAT3—lung cancer	6.74e-05	0.000275	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NRAS—lung cancer	6.72e-05	0.000275	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—lung cancer	6.72e-05	0.000275	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK3—lung cancer	6.44e-05	0.000263	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MYC—lung cancer	6.26e-05	0.000256	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT1—lung cancer	6.2e-05	0.000253	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGFR—lung cancer	6.12e-05	0.00025	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KRAS—lung cancer	5.78e-05	0.000237	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CA—lung cancer	5.31e-05	0.000217	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TP53—lung cancer	5.14e-05	0.00021	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CA—lung cancer	5.08e-05	0.000208	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HRAS—lung cancer	4.92e-05	0.000201	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—lung cancer	4.71e-05	0.000192	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT1—lung cancer	4.34e-05	0.000178	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKT1—lung cancer	4.15e-05	0.00017	CbGpPWpGaD
